⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1547421 | 0.89 | — | — | |
| SCHEMBL11354632 | 0.82 | NOS3 (0.37) | — | |
| SCHEMBL1277021 | 0.82 | — | — | |
| SCHEMBL771485 | 0.77 | — | — | |
| SCHEMBL32667642 | 0.75 | ALDH1A1 (0.37) | — | |
| SCHEMBL43433 | 0.75 | — | — | |
| SCHEMBL2150283 | 0.75 | ALDH1A1 (0.37) | — | |
| SCHEMBL2222242 | 0.75 | ALDH1A1 (0.37) | — | |
| SCHEMBL3962258 | 0.73 | CYP1A2 (0.58) | — | |
| Hydrogen Sulfide SCHEMBL5675254 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 354 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114315689-B | Disulfanylphthalimide compound, preparation method and application thereof | 四川大学 | 2023-04-07 | — | — | CN | claimed |
| US-20230027716-A1 | NOVEL PYRIDINYLTRIAZINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING CANCER COMPRISING SAME | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2023-01-26 | — | — | US | claimed |
| CN-114315689-A | Disulfanylphthalimide compound, preparation method and application thereof | 四川大学 | 2022-04-12 | — | — | CN | claimed |
| WO-2021080346-A1 | NOVEL PYRIDINYLTRIAZINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND PHARMACEUTICAL COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING CANCER COMPRISING SAME | 한국과학기술연구원 | 2021-04-29 | — | — | WO | claimed |
| US-9586936-B2 | Heteroarylamine derivatives as protein kinase inhibitors | KOREA INSTITITUE OF SCIENCE AND TECHNOLOGY (KR) | 2017-03-07 | — | — | US | claimed |
| US-20160145240-A1 | HETEROARYLAMINE DERIVATIVES AS PROTEIN KINASE INHIBITORS | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2016-05-26 | — | — | US | claimed |
| US-9150545-B2 | Carboxamide compounds and their use as calpain inhibitors V | AbbVie Deutschland GmbH & Co. KG (DE) | 2015-10-06 | — | — | US | claimed |
| US-20150065477-A1 | CARBOXAMIDE COMPOUNDS AND THEIR USE AS CALPAIN INHIBITORS V | AbbVie Deutschland GmbH & Co. KG (DE) | 2015-03-05 | — | — | US | claimed |
| EP-2834230-A1 | CARBOXAMIDE COMPOUNDS AND THEIR USE AS CALPAIN INHIBITORS V | AbbVie Deutschland GmbH & Co KG (DE) | 2015-02-11 | — | — | EP | claimed |
| EP-2831061-A1 | TRIAZOLE DERIVATIVES AS HSP90 INHIBITORS | Synta Pharmaceuticals Corp. (US) | 2015-02-04 | — | — | EP | claimed |
| WO-2003070727-A1 | THIAZOLYL UREA COMPOUNDS FOR THE TREATMENT OF CANCER | AMGEN INC. (US) | 2003-08-28 | — | — | WO | claimed |
| US-20020193405-A1 | Thiazolyl urea compounds and methods of uses | AMGEN INC. | 2002-12-19 | — | — | US | claimed |
| US-4925849-A | DIURETICS, HYPOTENSIVE AGENTS, CARIOTONIC AGENTS AND ANTIEDEMIC AGENTS | FUJISAWA PHARMACEUTICAL COMPANY, LTD. (JP) | 1990-05-15 | — | — | US | claimed |
| EP-0299209-A2 | Pyrazolopyridine compound and processes for preparation thereof | FUJISAWA PHARMACEUTICAL CO., LTD. (JP) | 1989-01-18 | — | — | EP | claimed |
| US-4599419-A | ANTICOAGULANTS | MITSUBISHI CHEMICAL INDUSTRIES, INC. (JP) | 1986-07-08 | — | — | US | claimed |
| US-4481365-A | POSTEMERGENCE | BAYER AKTIENGESELLSCHAFT (DE) | 1984-11-06 | — | — | US | claimed |
| US-4069323-A | INHIBITION AND SUPPRESSION OF THROMBOSIS | MITSUBISHI CHEMICAL INDUSTRIES LTD. (JA) | 1978-01-17 | — | — | US | claimed |
| US-4066758-A | ANTITHROMBOTIC | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JA) | 1978-01-03 | — | — | US | claimed |
| US-4062963-A | N2 -naphthalenesulfonyl-L-arginine derivatives, and the pharmaceutically acceptable acid addition salts thereof | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JA) | 1977-12-13 | — | — | US | claimed |
| US-4049645-A | ANTITHROMBOTIC AGENTS | MITSUBISHI CHEMICAL INDUSTRIES LIMITED (JA) | 1977-09-20 | — | — | US | claimed |